Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Sevoflurano Baxter 100% líquido para inhalación del vapor EFGRegistry product

    Linked study entry; product equivalence not established

    Formulation reported by source: INHALATION VAPOUR, LIQUID

    View study and source

Success Metrics

Active Trials
0(0%)

Phase Distribution

Phase 3
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

not_yet_recruiting1100%

Recent Activity

0 active trials
Showing 1 of 1
not_yet_recruitingphase_3

SAVE trial

SYF9bec83a85c564e98a1c90df65dac102f

Clinical Trials (1)

Showing 1 of 1 trials
SYF9bec83a85c564e98a1c90df65dac102fPhase 3

SAVE trial

Not Yet Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Type not reported
Total Trials
1